Has Joseph Rossano received payments from drug or device companies?

Yes. Drug and device makers reported $54,748 in general payments to Joseph Rossano across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joseph Rossano did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joseph Rossano come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joseph Rossano

Pediatric Cardiology · Philadelphia, PANPI 1346407558

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Merck at 59.8% of the total. Among pediatric cardiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,748in general payments, 2019–2025

Across 97 payments — averaging $564.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$33K
Sumitomo Pharma America, Inc.$6K
E.r. Squibb & Sons, L.L.C.$6K
CSL Behring$4K
Abiomed$3K
Abbott$2K
plus $216 from 2 others

$401,234in research payments, 2019–2025

Across 48 payments — averaging $8359.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$179K
Pfizer$87K
E.r. Squibb & Sons, L.L.C.$64K
Merck$45K
Janssen Research & Development, LLC$22K
American Regent$3K
plus $3K from 1 others

What the payments were for

Consulting fees$8,89816%
Speaking & faculty fees$12,14022%
Travel & lodging$31,08757%
Food & beverage$2,6245%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	53	$32,715
Sumitomo Pharma America, Inc.	6	$6,491
E.r. Squibb & Sons, L.L.C.	4	$5,579
CSL Behring	5	$3,922
Abiomed	5	$3,431
Abbott	20	$2,396
Novartis	3	$173
Bayer	1	$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,748 in reported general payments places this provider in the 95th percentile of 102 pediatric cardiology providers in Pennsylvania.

See all pediatric cardiology providers in Pennsylvania →

Other pediatric cardiology in Philadelphia

Matthew GillespiePhiladelphia$1.5M
Catherine AvitabilePhiladelphia$66K
Jonathan EdwardsPhiladelphia$65K
Jack RychikPhiladelphia$30K
Robert ShaddyPhiladelphia$23K
Carol Wittlieb-WeberPhiladelphia$21K
Sunita FernsPhiladelphia$20K
Jonathan EdelsonPhiladelphia$19K
Julie BrothersPhiladelphia$11K
Catherine TomasuloPhiladelphia$10K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →